Working… Menu
Trial record 7 of 16 for:    LENALIDOMIDE AND Leukemia AND Azacitidine

Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01301820
Recruitment Status : Completed
First Posted : February 23, 2011
Last Update Posted : March 16, 2016
Celgene Corporation
Information provided by (Responsible Party):
French Innovative Leukemia Organisation

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2013
Actual Study Completion Date : February 2013